Cost of Revenue
$2.51B
TTM · Period ending: · USD
MRNA Cost of Revenue
Latest reported$2.51Bperiod ending
Latest reported$2.51Bperiod ending
MRNA TTM Cost of Revenue ($210.06M → $2.51B)
TTM cost of revenue
High-resolution chart · PNG
MRNA cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 2,508,000,000 | |
| 2,534,000,000 | |
| 1,669,000,000 | |
| 1,956,000,000 | |
| 1,462,000,000 | |
| 1,458,000,000 | |
| 1,464,000,000 | |
| 1,654,000,000 | |
| 3,381,000,000 | |
| 3,997,000,000 | |
| 4,693,000,000 | |
| 5,682,000,000 | |
| 4,541,000,000 | |
| 5,191,000,000 | |
| 5,416,000,000 | |
| 4,450,000,000 | |
| 4,072,000,000 | |
| 3,441,000,000 | |
| 2,617,000,000 | |
| 1,680,639,000 | |
| 967,139,000 | |
| 224,739,000 | |
| 39,188,000 | |
| 32,488,000 | |
| 31,288,000 | |
| 31,188,000 | |
| 31,055,000 | |
| 29,466,000 | |
| 28,647,000 | |
| 125,626,000 | |
| 208,434,000 | |
| 206,999,000 | |
| 205,648,000 | |
| 200,678,500 | |
| 210,064,000 |